A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus
Clinical trial NCT02725515 · COMPLETED
Trial details
- NCT number
- NCT02725515
- Sponsor
- Xencor, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-16
- Primary completion
- 2018-07-17
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.